ACE2 and Abdominal obesity: In addition, it has been observed that ACE2 is expressed at higher levels in abdominal visceral fat than in subcutaneous fat, which would increase the production of inflammatory cytokines and their release into the systemic circulation and may contribute to an amplified “cytokine storm” in patients with abdominal obesity and high visceral adiposity [17].